Sat, Apr 19, 2014, 11:02 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Alimera Sciences, Inc. (ALIM) Message Board

  • frankie1x frankie1x Oct 21, 2013 5:27 AM Flag

    European potential for ILUVIEN from SA article 10/7/13 Bobs stock, psivida strong takeover target

    Approximately 10% of diabetics will develop Diabetic Macular Edema. The proposed price for Iluvien in Europe will be somewhere between $5,500 to $8,800. For the purpose of this article I will use the average, which is $7150.

    Austria:

    Has approximately 400,000 diabetics

    400,000 * 0.10 = 40,000 potential patients

    40,000 * $7150 = $286,000,000 sales

    Portugal:

    Has approximately 900,000 diabetics

    900,000 * 0.10 = 90,000 potential patients

    90,000 * $7150 = $643,500,000 sales

    France:

    Has approximately 3,945,753 diabetics

    3,945,753 * 0.10 = 394,575 potential patients

    394,575 * $7150 = $2,821,211,250 sales

    Spain:

    Has approximately 3,635,946 diabetics

    3,635,946 * 0.10 = 363,594 potential patients

    363,594 * $7150 = $2,599,697,100 sales

    Germany:

    Has approximately 7,372,226 diabetics

    7,372,226 * 0.10 = 737,222 potential patients

    737,222 * $7150 = $5,271,137,300 sales

    United Kingdom (I will use a cost of $5500 for the U.K. since it is most likely to be lower in the U.K.):

    Has approximately 3,636,375 diabetics

    3,636,375 * 0.10 = 363,637 potential patients

    363,637 * $5500 = $2,000,003,500 sales

    Approximately 10% of diabetics will develop Diabetic Macular Edema. The proposed price for Iluvien in Europe is between $5,500 and $8,800. For the purposes of this article I will use the average, which is $7150.

    Using these conservative estimates, the potential revenue possibilities are enormous. pSivida fully diluted share count is 23,297,011. At today's price per share value of $4.78, it would have a market capitalization of around $110 million. If the company produces even 15% of the above projected revenues, this would equate to $2.1 billion. This is excluding the U.S. market, which I feel will be a slam dunk approval later this year.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ALIM
6.31+0.01(+0.16%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT